170104-85-5

Upstream product

• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 887275-10-7 N-{3-[4-(4-cyanomethyl-piperazin-1-yl)-3,5-difluoro-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-2,2-difluoro-acetamide 
• 887275-13-0 (S)-N-[[3-[3,5-difluoro-4-[4-(cyanomethyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]thioacetamide 
• 887275-06-1 {(S)-3-[4-(4-Cyanomethyl-piperazin-1-yl)-3,5-difluoro-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-carbamic acid methyl ester 
• 887275-17-4 (S)-N-[[3-[3,5-difluoro-4-[4-(cyanomethyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]-methyl]-O-methylthiocarbamate 
• 154590-67-7 N-{3-[4-(4-cyanomethyl-piperazin-1-yl)-3,5-difluoro-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide 
• 887274-96-6 {4-[4-((R)-5-Azidomethyl-2-oxo-oxazolidin-3-yl)-2,6-difluoro-phenyl]-piperazin-1-yl}-acetonitrile 
• 887275-00-5 {4-[4-((S)-5-Aminomethyl-2-oxo-oxazolidin-3-yl)-2,6-difluoro-phenyl]-piperazin-1-yl}-acetonitrile 
• 170104-86-6 4-[4-((5R)-5-azidomethyl-2-oxo-oxazolidin-3-yl)-2,6-difluoro-phenyl]-piperazine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent

Novel oxazolidinone antibacterials containing N-hydroxyacetamidine moiety are synthesized with the diversity at C-5 terminus. These compounds have been evaluated against a panel of clinically relevant Gram-positive and Gram-negative pathogens. Most of the

NOVEL ANTIMICROBIALS

The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the